Login

Mr. David Sin is the Co-Founder, Group President, and Deputy Chairman of the Board of Fullerton Health, and an alumnus of The Chinese High School. 00:10:00

Share On Facebook Share On Twitter

Chang Ching Wu CEO. Chief Executive Officer

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Delivering a High-Quality Copper Project with Strategic Partnerships in Northern Peru.
00:10:00
GTK Director Discusses Sustainable Resource Use and Circular Economy Solutions
00:10:00
Lithium Australia's Strategic Moves: Mike Discusses Acquisition and Future Plans at One-to-One Mining Conference
00:10:00
Panel Discussion on Strategic Assessments
00:10:00
The former Engility president and CEO discusses Science Applications International Corp.'s international development service portfolio.
00:10:00
Silver Mountain Resources: Revitalizing Mining Operations in Peru
00:10:00
Tenable CEO Amit Yoran discusses the ransomware attack on UnitedHealthcare during a CNN interview.
00:10:00
VC that helps founders build defensible moats|Mike Zajko,Partner,Lattice
00:10:00
Rumble Resources Zinc-Lead-Copper Discoveries and Exploration Updates
00:10:00
Presentation on the Nyanzaga Gold Project in Tanzania by OreCorp Ltd.
00:10:00
Avaada’s Vineet Mittal Discusses Renewable Energy at ETRenewableEnergy Conclave | Vineet Mittal , Chairman , Avada Group.
00:10:00
AEW UK REIT review the trust's investment objectives, how they generate investment ideas and how the trust has performed over the last five years|Portfolio Manager,AEW UK REIT plc

© 2026 Nehu